Helen A Fletcher Selected Research

MVA 85A

1/2017	Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study.
1/2011	A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adults.
8/2008	Safety and immunogenicity of the candidate tuberculosis vaccine MVA85A in West Africa.
10/2007	Boosting BCG with recombinant modified vaccinia ankara expressing antigen 85A: different boosting intervals and implications for efficacy trials.
8/2006	Early clinical trials with a new tuberculosis vaccine, MVA85A, in tuberculosis-endemic countries: issues in study design.
1/2005	Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials.
11/2004	Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Helen A Fletcher Research Topics

Disease

48	Tuberculosis (Tuberculoses) 01/2021 - 01/2003
17	Infections 01/2020 - 02/2003
6	Malaria 09/2015 - 12/2009
4	Communicable Diseases (Infectious Diseases) 10/2018 - 07/2010
2	Melioidosis 01/2020 - 01/2018
2	Inflammation (Inflammations) 01/2020 - 01/2013
2	Human Influenza (Influenza) 02/2013 - 01/2011
2	Vaccinia 08/2008 - 10/2007
1	Immune Reconstitution Inflammatory Syndrome 01/2022
1	Hypoxia (Hypoxemia) 01/2019
1	Leishmaniasis 01/2018
1	Leprosy (Hansen's Disease) 01/2018
1	Disease Progression 01/2016
1	Noncommunicable Diseases 10/2015
1	Alcoholism (Alcohol Abuse) 10/2015
1	HIV Infections (HIV Infection) 01/2011
1	Rabies (Hydrophobia) 12/2009
1	Cicatrix (Scar) 08/2008
1	Body Remains 02/2003

Drug/Important Bio-Agent (IBA)

41	VaccinesIBA 01/2021 - 01/2005
7	AntigensIBA 01/2019 - 11/2004
7	MVA 85AIBA 01/2017 - 11/2004
6	BCG Vaccine FDA Link 01/2021 - 05/2007
6	Interferon-gamma (Interferon, gamma)IBA 01/2018 - 09/2010
5	Biomarkers (Surrogate Marker)IBA 01/2020 - 05/2007
5	CytokinesIBA 01/2019 - 07/2010
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 09/2010
4	Tuberculin (PPD)IBA 01/2019 - 01/2016
3	InterleukinsIBA 01/2020 - 08/2004
3	Malaria VaccinesIBA 09/2015 - 09/2010
2	AntibodiesIBA 01/2020 - 01/2016
2	Glyburide (Glibenclamide)FDA LinkGeneric 01/2020 - 01/2018
2	Immunoglobulin G (IgG)IBA 01/2020 - 01/2016
2	InterferonsIBA 01/2020 - 01/2017
2	RNA (Ribonucleic Acid)IBA 07/2014 - 01/2011
2	Interleukin-17 (Interleukin 17)IBA 01/2013 - 07/2010
2	Subunit VaccinesIBA 01/2005 - 11/2004
2	DNA (Deoxyribonucleic Acid)IBA 02/2003 - 01/2003
1	Dinoprostone (PGE2)FDA Link 01/2020
1	Interleukin-8 (Interleukin 8)IBA 01/2020
1	Interleukin-23 (Interleukin 23)IBA 01/2019
1	sapropterin (tetrahydrobiopterin)FDA Link 12/2018
1	GoldIBA 01/2017
1	insulin receptor-related receptor (IRR)IBA 01/2017
1	EpitopesIBA 01/2016
1	Detergents (Detergent)IBA 01/2016
1	Nucleic AcidsIBA 10/2015
1	Volatile Organic CompoundsIBA 10/2015
1	EnzymesIBA 07/2014
1	ImmunosorbentsIBA 07/2014
1	AerosolsIBA 01/2013
1	Cholera ToxinIBA 01/2013
1	Interleukin-10 (Interleukin 10)IBA 09/2010
1	Messenger RNA (mRNA)IBA 09/2010
1	Transforming Growth Factors (Transforming Growth Factor)IBA 09/2010
1	Tuberculosis VaccinesIBA 08/2006
1	AcidsIBA 02/2003

Therapy/Procedure

1	Art Therapy 01/2022
1	Duration of Therapy 10/2015
1	Therapeutics 05/2007
1	Drug Therapy (Chemotherapy) 05/2007